| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/13/2005 | US20050009040 Using probes/primers of mutant microsatellite nucleotide sequence to diagnose/prognose cell proliferative disorders of lung, head and neck |
| 01/13/2005 | US20050009038 Using genomic DNA and primers comprising a-selective bases as diagnostic tool in resolving hereditary relationships between animal and bird species |
| 01/13/2005 | US20050009036 Proteases, zwitterionic compound (such as n-Octyl-N,N-dimethyl-3-ammonio-1-propanesulfonate), and chaotrope (guanidine hydrochloride); solid phase synthesis; kits |
| 01/13/2005 | US20050009030 Histone deacetylase: novel molecular target of neurotoxicity |
| 01/13/2005 | US20050009029 Expression system |
| 01/13/2005 | US20050009028 Using tagged ribosomes as diagnostic tool in detection and isolation of preferential translated messenger RNA species; tissue targeted therapy |
| 01/13/2005 | US20050009027 Using single stranded primer and reverse transcription to generate multiple single stranded RNAs; gene amplification; microarray analysis and genomics; gene expression analysis |
| 01/13/2005 | US20050009025 A soluble T cell receptor for use as diagnostic indicator of infection and autoimmune diseases |
| 01/13/2005 | US20050009024 Using allelic variance in carboxypeptidase gene as diagnostic indicator of cardiovascular disease |
| 01/13/2005 | US20050009022 Method for isolation of independent, parallel chemical micro-reactions using a porous filter |
| 01/13/2005 | US20050009021 Isolated nucleic acid comprising polynucleotide of given sequence; diagnostic kits; use in treatment of cancer |
| 01/13/2005 | US20050009019 Engineered microbial yeast comprising nucleotide sequence encoding kinase or phosphatase that modulates phosphorylation; useful in screening therapeutic agents for Alzheimer's disease |
| 01/13/2005 | US20050009017 Alpha-isomaltosyltransferase, process for producing the same and use thereof |
| 01/13/2005 | US20050009015 Method for relative quantification of attached nucleic acids |
| 01/13/2005 | US20050009013 Preparing transfer RNA-coumarin marker conjugates for non-radioactive detection and analysis of translation |
| 01/13/2005 | US20050009012 Genome comprising polynucleotide encoding promoter linked to a transcription unit encoding a fusion protein; autoproteolytic peptide |
| 01/13/2005 | US20050008654 For prevention, therapy of sepsis shock, thrombosis disorders |
| 01/13/2005 | US20050008651 Modulating replication via immunogen and pharmaceutically or veterinarily acceptable vehicles |
| 01/13/2005 | US20050008650 Chemical modification of single chain polypeptides by means of covalent attachment of strands of polyethylene glycol to single chain polypeptide binding molecules that have three dimensional folding and binding ability |
| 01/13/2005 | US20050008645 Antibodies Specific For Phosphatase Subunit of LAR |
| 01/13/2005 | US20050008642 Antibodies against insulin-like growth factor 1 receptor and uses thereof |
| 01/13/2005 | US20050008637 Cancer therapy; antiinflammatory agents; autoimmune disease |
| 01/13/2005 | US20050008635 Humanized antibodies that bind to the antigen bound by antibody NR-LU-13 and their use in pretargeting methods |
| 01/13/2005 | US20050008617 Compositions and methods for delivery of short interfering RNA and short hairpin RNA |
| 01/13/2005 | CA2756586A1 Modulation of survivin expression |
| 01/13/2005 | CA2728746A1 Methods of amplifying and sequencing nucleic acids |
| 01/13/2005 | CA2727850A1 Methods of amplifying and sequencing nucleic acids |
| 01/13/2005 | CA2568859A1 Cytokine variant polypeptides |
| 01/13/2005 | CA2542192A1 Look-through mutagenesis |
| 01/13/2005 | CA2531647A1 Food additive comprising pseudomonas non-maltogenic exoamylase variants |
| 01/13/2005 | CA2531367A1 Method of preparing transgenic organism with use of methylation and system therefor |
| 01/13/2005 | CA2531362A1 Methods for microparticle multiplex detection |
| 01/13/2005 | CA2531321A1 Rna processing protein complexes and uses thereof |
| 01/13/2005 | CA2531240A1 An endogenous peptide and active subfragments thereof |
| 01/13/2005 | CA2531185A1 Novel rubisco promoters and uses thereof |
| 01/13/2005 | CA2531106A1 Methods and means for regulating gene expression |
| 01/13/2005 | CA2531051A1 Method of producing double low restorer lines of brassica napus having a good agronomic value |
| 01/13/2005 | CA2530530A1 Methods and compositions for enhanced protein expression and purification |
| 01/13/2005 | CA2530427A1 Elevation of oil levels in plants |
| 01/13/2005 | CA2530304A1 Method for the isolation of expressed sequence tags in plants |
| 01/13/2005 | CA2529559A1 Erk7 and erk8, novel diagnostic markers for cancer |
| 01/13/2005 | CA2529403A1 Glucanases, nucleic acids encoding them and methods for making and using them |
| 01/13/2005 | CA2529058A1 Increased t-cell tumor infiltration by mutant light |
| 01/13/2005 | CA2528963A1 Rna interference mediated treatment of alzheimer's disease using short interfering nucleic acid (sina) |
| 01/13/2005 | CA2528860A1 Recombinant antibodies and compositions and methods for making and using the same |
| 01/13/2005 | CA2528686A1 Dna-based aptamers for human cathepsin g |
| 01/13/2005 | CA2528140A1 Nod-factor perception |
| 01/13/2005 | CA2528109A1 Methods for enhancing gene expression analysis |
| 01/13/2005 | CA2528094A1 Expression vectors for stimulating an immune response to cancer antigens |
| 01/13/2005 | CA2527877A1 Unnatural reactive amino acid genetic code additions |
| 01/13/2005 | CA2527089A1 Acyltransferases for alteration of polyunsaturated fatty acids and oil content in oleaginous yeasts |
| 01/13/2005 | CA2526896A1 Glyceraldehyde-3-phosphate dehydrogenase and phosphoglycerate mutase promoters for gene expression in oleaginous yeast |
| 01/13/2005 | CA2526480A1 Modified starch, uses, methods for production thereof |
| 01/13/2005 | CA2524495A1 Modulation of survivin expression |
| 01/13/2005 | CA2517684A1 Compositions and methods for diagnosing and treating asthma or other allergic or inflammatory diseases |
| 01/13/2005 | CA2513899A1 Methods of amplifying and sequencing nucleic acids |
| 01/13/2005 | CA2510653A1 Prna chimera |
| 01/13/2005 | CA2494798A1 Ap1 amine oxidase variants |
| 01/12/2005 | EP1496364A2 Cloning and expression of gonadotropin-releasing hormone receptor |
| 01/12/2005 | EP1496359A1 Substrates for hybridization and method of using the same |
| 01/12/2005 | EP1496125A2 Genetic transformation using a PARP inhibitor |
| 01/12/2005 | EP1496124A1 Catalytically active recombinant memapsin and methods of use thereof |
| 01/12/2005 | EP1496123A1 Genes encoding acetolactate synthase |
| 01/12/2005 | EP1496122A1 Novel meloidogyne-resistance gene and utilization thereof |
| 01/12/2005 | EP1496121A2 Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides |
| 01/12/2005 | EP1496120A2 In vitro sorting method |
| 01/12/2005 | EP1496118A1 Method of measuring human cyp3a inducibility |
| 01/12/2005 | EP1496117A1 Selection marker gene |
| 01/12/2005 | EP1496115A1 Process for producing canthaxanthin |
| 01/12/2005 | EP1496113A1 Gluconate dehydratase |
| 01/12/2005 | EP1496112A2 Neutral Proteas (NP) and its use in dissociation of tissues |
| 01/12/2005 | EP1496111A2 Variants of 3-Phosphoglycerate dehydrogenase with reduced inhibition by L-serine and genes encoding the same |
| 01/12/2005 | EP1496110A1 Method of proliferating human hepatocytes and method of obtaining human hepatocytes |
| 01/12/2005 | EP1496107A2 Apparatus and method for efficient incorporation of molecules into cells |
| 01/12/2005 | EP1495672A1 Functional plant, promoter to be used for producing the functional plant and method of using the same |
| 01/12/2005 | EP1495670A1 Plant transformation system |
| 01/12/2005 | EP1495330A1 Method of identifying transmembrane protein-interacting compounds |
| 01/12/2005 | EP1495322A2 Heteroclitic analogs and related methods |
| 01/12/2005 | EP1495145A2 Phage display affinity and specificity filters and forward screen |
| 01/12/2005 | EP1495142A1 "doping" in walk-through mutagenesis |
| 01/12/2005 | EP1495141A2 Hiv therapeutic |
| 01/12/2005 | EP1495139A2 Methods and compositions for detection and quantitation of nucleic acid analytes |
| 01/12/2005 | EP1495138A1 Detection of proteins interactions |
| 01/12/2005 | EP1495137A1 New method |
| 01/12/2005 | EP1495136A2 Nucleic acid quantification |
| 01/12/2005 | EP1495135A2 Rapid and specific detection of campylobacter |
| 01/12/2005 | EP1495131A2 Process control based on microbiological activity |
| 01/12/2005 | EP1495130A1 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 01/12/2005 | EP1495128A1 Ehanced protein expression in bacillus |
| 01/12/2005 | EP1495125A2 Vac-bac shuttle vector system |
| 01/12/2005 | EP1495124A2 Smac-peptides as therapeutics against cancer and autoimmune diseases |
| 01/12/2005 | EP1495123A1 Erbb3 based methods and compositions for treating neoplasms |
| 01/12/2005 | EP1495122A1 Antiviral therapy on the basis of rna interference |
| 01/12/2005 | EP1495121A2 Means and methods for the specific inhibition of genes in cells and tissue of the cns and/or eye |
| 01/12/2005 | EP1495120A2 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification |
| 01/12/2005 | EP1495119A2 Method and apparatus for extracting nucleic acids from a complex mixture |
| 01/12/2005 | EP1495118A2 High level expression of immunogenic proteins in the plastids of higher plants |
| 01/12/2005 | EP1495117A2 Human deubiquitinating protease gene on chromosome 7 and its murine ortholog |
| 01/12/2005 | EP1495116A1 Saccharomyces cerevisiae yeast strain with improved phytase activity |
| 01/12/2005 | EP1495115A2 Nucleic acid sequence and protein in addition to polypeptides coding for mannitol-dehydrogenases or parts thereof and the production and use thereof in diagnosis and therapy |